Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AorTech International PLC

www.aortech.com

Latest From AorTech International PLC

Best of the Blog START-UP February 2009

A selection of our best blog posts from February for stories not covered elsewhere in the magazine includes: Friends in High Places: The White House appears to appreciate the need for innovation and, Medtronic's $1.03 billion buying spree is only the beginning in percutaneous heart valves.

Percutaneous Heart Valve Technology: The Mitral Challenge

While there is no question that heart valve repair and replacement is moving toward minimally invasive techniques and devices, there is a big difference between a minimally invasive surgical approach and a truly percutaneous, incisionless procedure. The challenges of reaching the latter goal are substantial, but apparently not insurmountable., In fact, recent progress in this field provides hope that in the not too distant future, percutaneous valve replacement and repair will become an accepted part of the treatment armamentarium, greatly expanding the number of patients who can be offered these potentially life-saving procedures.
Medical Device

Beauty: In the Eye of the Stakeholder

A $12-billion market and growing, the field of aesthetic medicine has exploded with new treatments and techniques for improving and restoring the quality, health and appearance of aging skin. Techniques such as tissue tightening, skin resurfacing, cellulite treatments, dermal augmentation, and fat removal are just some of the new advancements in aesthetic medicine that were highlighted at the 2007 American Academy of Dermatology meeting.
Medical Device Platform Technologies

Deal Statistics Quarterly, Q2 2001

In Vivo presents another installment of our quarterly review of dealmaking--in this case April 2001-June 2001. Our data comes from Windhover's Strategic Transactions Database. We include medical device financings by industry segment and by deal type; medical device M&A; diagnostic financings and alliances by product category; pharma and biotech alliances by technology segment; pharma and biotech alliances by deal type, and pharma and biotech financings by market segment and therapeutic category.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • AorTech International PLC
  • Senior Management
  • William Strachan, CEO
    Edward McDaid, Chmn.
    Peter Duijst, Medical & Reg. Dir.
    John McKenna, Sales & Mktg. Dir.
    Ian Cameron, Dir., Fin.
    David Williams, Dev. Dir.
  • Contact Info
  • AorTech International PLC
    Phone: (44) 1698 746699
    Strathclyde Business Park
    Bellshill, Ml4 3NJ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register